Human gene therapy - JoVE Visualize

Showing results (3221-3230 of 4,130) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|February 1, 1992

Hearing on the possible uses and misuses of genetic informationB Healy

Human Gene Therapy|December 9, 2004

Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cellsPasquale Cirone, Jacqueline M Bourgeois, Feng Shen, et al.

Human Gene Therapy|December 22, 2004

Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivoLaura Denby, Lorraine M Work, Delyth Graham, et al.

Human Gene Therapy|December 22, 2004

Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombinationSamuel K Campos, Michael A Barry

Human Gene Therapy|December 22, 2004

Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosisRonald G Crystal, Dolan Sondhi, Neil R Hackett, et al.

Human Gene Therapy|February 11, 2005

Helper-dependent adenoviral vectors for gene therapyDonna J Palmer, Philip Ng

Human Gene Therapy|February 11, 2005

Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vectorPeter Manilla, Tessio Rebello, Cathleen Afable, et al.

Human Gene Therapy|February 11, 2005

DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimenTae Woo Kim, Jin-Hyup Lee, Liangmei He, et al.

Human Gene Therapy|February 11, 2005

Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectorsDeborah J Watson, Marco A Passini, John H Wolfe

Human Gene Therapy|February 11, 2005

Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vectorCarmela Di Domenico, Guglielmo R D Villani, Daniele Di Napoli, et al.

Pageof 413

Showing results (3221-3230 of 4,130) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|February 1, 1992

Hearing on the possible uses and misuses of genetic informationB Healy

Human Gene Therapy|December 9, 2004

Combined immunotherapy and antiangiogenic therapy of cancer with microencapsulated cellsPasquale Cirone, Jacqueline M Bourgeois, Feng Shen, et al.

Human Gene Therapy|December 22, 2004

Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivoLaura Denby, Lorraine M Work, Delyth Graham, et al.

Human Gene Therapy|December 22, 2004

Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombinationSamuel K Campos, Michael A Barry

Human Gene Therapy|December 22, 2004

Clinical protocol. Administration of a replication-deficient adeno-associated virus gene transfer vector expressing the human CLN2 cDNA to the brain of children with late infantile neuronal ceroid lipofuscinosisRonald G Crystal, Dolan Sondhi, Neil R Hackett, et al.

Human Gene Therapy|February 11, 2005

Helper-dependent adenoviral vectors for gene therapyDonna J Palmer, Philip Ng

Human Gene Therapy|February 11, 2005

Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vectorPeter Manilla, Tessio Rebello, Cathleen Afable, et al.

Human Gene Therapy|February 11, 2005

DNA vaccines employing intracellular targeting strategies and a strategy to prolong dendritic cell life generate a higher number of CD8+ memory T cells and better long-term antitumor effects compared with a DNA prime-vaccinia boost regimenTae Woo Kim, Jin-Hyup Lee, Liangmei He, et al.

Human Gene Therapy|February 11, 2005

Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectorsDeborah J Watson, Marco A Passini, John H Wolfe

Human Gene Therapy|February 11, 2005

Gene therapy for a mucopolysaccharidosis type I murine model with lentiviral-IDUA vectorCarmela Di Domenico, Guglielmo R D Villani, Daniele Di Napoli, et al.

Pageof 413